Pennant Net Income Over Time
| PNTG Stock | USD 31.97 0.81 2.60% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Pennant Performance and Pennant Correlation. Can Health Care Providers & Services industry sustain growth momentum? Does Pennant have expansion opportunities? Factors like these will boost the valuation of Pennant. Anticipated expansion of Pennant directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Pennant demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth (0.15) | Earnings Share 0.75 | Revenue Per Share | Quarterly Revenue Growth 0.268 | Return On Assets |
The market value of Pennant Group is measured differently than its book value, which is the value of Pennant that is recorded on the company's balance sheet. Investors also form their own opinion of Pennant's value that differs from its market value or its book value, called intrinsic value, which is Pennant's true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because Pennant's market value can be influenced by many factors that don't directly affect Pennant's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Pennant's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pennant should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Pennant's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Net Income Analysis
Compare Pennant Group and related stocks such as AMN Healthcare Services, CorMedix, and Integra LifeSciences Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMN | (5.2 M) | (26.3 M) | 17.1 M | 32.9 M | 33.2 M | 81.9 M | 105.8 M | 132.6 M | 141.7 M | 114 M | 70.7 M | 327.4 M | 444.1 M | 210.7 M | (147 M) | (169 M) | (160.6 M) |
| CRMD | (9 M) | (6.7 M) | (3.4 M) | (9.1 M) | (20.5 M) | (18.2 M) | (24.6 M) | (33 M) | (26.8 M) | (16.4 M) | (22 M) | (28.2 M) | (29.7 M) | (46.3 M) | (17.9 M) | (16.1 M) | (16.9 M) |
| IART | (25.4 M) | 28 M | 41.2 M | (17 M) | 34 M | (3.5 M) | 74.6 M | 64.7 M | 60.8 M | 50.2 M | 133.9 M | 169.1 M | 180.6 M | 67.7 M | (6.9 M) | (8 M) | (7.6 M) |
| SNDA | 3.7 M | 3 M | (3.1 M) | (16.5 M) | (24.1 M) | (14.3 M) | (28 M) | (44.2 M) | (53.6 M) | (36 M) | (295.4 M) | 125.6 M | (54.4 M) | (21.1 M) | (2.1 M) | (1.9 M) | (1.9 M) |
| BCAX | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (52 M) | (68 M) | (61.2 M) | (64.3 M) |
| EYPT | (2.3 M) | (8.6 M) | (24.8 M) | (11.9 M) | (13.4 M) | 6.3 M | (21.5 M) | (18.5 M) | (53.2 M) | (56.8 M) | (45.4 M) | (58.4 M) | (102.3 M) | (70.8 M) | (130.9 M) | (117.8 M) | (111.9 M) |
| PROK | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (26.7 M) | (55.1 M) | (108 M) | (35.5 M) | (61.2 M) | (70.4 M) | (73.9 M) |
| INNV | (4.8 M) | (4.8 M) | (4.8 M) | (4.8 M) | (4.8 M) | (4.2 M) | (13.7 M) | (6.5 M) | 19.6 M | 26.3 M | (44 M) | (6.5 M) | (40.7 M) | (21.3 M) | (30.3 M) | (27.3 M) | (25.9 M) |
| HSTM | (4.5 M) | 6.9 M | 7.6 M | 8.4 M | 10.4 M | 8.6 M | 3.8 M | 10 M | 32.2 M | 15.8 M | 14.1 M | 5.8 M | 12.1 M | 15.2 M | 20 M | 23 M | 24.2 M |
| KURA | (33.6 K) | (22.4 K) | (27 K) | (27.3 K) | (11 M) | (22.6 M) | (27.6 M) | (35.4 M) | (60.4 M) | (63.1 M) | (89.6 M) | (130.5 M) | (135.8 M) | (152.6 M) | (174 M) | (156.6 M) | (148.8 M) |
Pennant Group and related stocks such as AMN Healthcare Services, CorMedix, and Integra LifeSciences Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Pennant Group financial statement analysis. It represents the amount of money remaining after all of Pennant Group operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Pennant Group | PNTG |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 1675 East Riverside |
| Exchange | NASDAQ Exchange |
USD 31.97
Check out Pennant Performance and Pennant Correlation. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Pennant technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.